Abzena is a CDMO and CRO providing discovery-to-commercial development and cGMP manufacturing for antibodies, recombinant proteins, bioconjugates, antibody-drug conjugates (ADCs), and complex biologics. Its single-use manufacturing capabilities support clinical and commercial drug-substance manufacturing at scales up to 2,000 L, with quality and regulatory systems supporting global filings. Read more about the partnership in this press release.

Locations:

This website uses cookies to enhance your browsing experience and ensure the site functions properly. By continuing to use this site, you acknowledge and accept our use of cookies.

Accept All Accept Required Only